Chronic kidney disease, stage 5. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Doining dialysis with 35 ° C dialysate in experimental group. Intervention 2: Doing dialysis with 37 ° C dialysate in control group.
Prevention
Doining dialysis with 35 ° C dialysate in experimental group
Doing dialysis with 37 ° C dialysate in control group
Sponsors
Vice chancellor for research and technology of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having a written consent for participation in the study; being between the age of 18-70; having some degrees of sleep disturbance and fatigue based on the questionnaire; undergoing a dialysis treatment twice or three times a week; undergoing a hemodialysis treatment for at least 6 months; having no experience of participating in similar research; having a hemoglobin level >10md/dl; having no history of crisis in the last 6 months; having no history of mental disease such as major depression; having no history of using depressants; having no history of active cancer; and severe infection. Exclusion criteria: having an incidence of severe crisis; being diagnosed with incurable diseases such as cancer; kidney transplantation at the time of the study; having no incidence of hemodynamic complications during the most of dialysis sessions; unwillingness to continue participating in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality and post dialysis fatigue. Timepoint: once before the study,3 times during intervention and 1 after ending the intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSalahshourniat Fathemeh
Mashhad University of Medical Sciences
Outcome results
None listed